ESR1 and cancer: The role of SLC6A14 in supply of amino acids to cancer cells appears confirmed as SLC6A14 knockout leads to a decrease in tumour growth in mouse models of estrogen receptor positive breast cancer [32] and pancreatic cancer [33].